Amrein1, Colecchi, Finkelstein
1Hematology-Oncology Unit, Massachusetts General Hospital, Boston, Massachusetts, 02114, USA. Amrein.Philip@MGH.Harvard.edu
Adjuvant chemotherapy after standard treatment for head and neck cancer shows promising survival rates. This study suggests further randomized trials are needed to confirm the benefits of this moderately intensive chemotherapy regimen.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: